Jiangsu Genscend Biopharmaceutical Co., Ltd
Clinical trials sponsored by Jiangsu Genscend Biopharmaceutical Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New biosimilar aims to rival blockbuster eczema drug Results expected Sep 2026 (estimated)
- New eczema drug GS101 takes on dupixent in major trial Results expected Apr 2027 (estimated)